Monograph Details
|
|
Respiratory Tract
> Rhinitis/rhinorrhea (intranasal products)
|
|
PATANASE |
| Manufacturer |
|
Alcon Laboratories, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Antihistamine (H1-blocker). |
| Generic Name |
|
Olopatadine (as HCl) 0.6% (665mcg/spray); aqueous nasal spray; contains benzalkonium chloride. |
| Indications |
|
Seasonal allergic rhinitis. |
| Children |
|
Not recommended. |
| Adults |
|
2 sprays in each nostril twice daily. |
| Precautions |
|
Other nasal diseases: not recommended. Avoid eyes. Monitor for nasal mucosal changes. Pregnancy (Cat.C). Nursing mothers. |
| Interactions |
|
Potentiates CNS depression with alcohol, other CNS depressants. |
| Adverse Reactions |
|
Bitter taste, headache, epistaxis, throat pain, post-nasal drip, cough, nasal ulceration, somnolence. |
| How Supplied |
|
Nasal spray pump—30.5g (240 sprays) |
|
|
|
|
